Related references
Note: Only part of the references are listed.Proteolysis targeting chimeras in antiviral research
Jenny Desantis et al.
FUTURE MEDICINAL CHEMISTRY (2022)
Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation
Yuzheng Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
PROTAC targeted protein degraders: the past is prologue
Miklos Bekes et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Targeted protein degraders march towards the clinic for neurodegenerative diseases
Md. Imtaiyaz Hassan et al.
AGEING RESEARCH REVIEWS (2022)
Discovery of Pentacyclic Triterpenoid PROTACs as a Class of Effective Hemagglutinin Protein Degraders
Haiwei Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA
Jianyuan Zhao et al.
NATURE COMMUNICATIONS (2022)
BacPROTACs mediate targeted protein degradation in bacteria
Francesca E. Morreale et al.
CELL (2022)
Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy
Jing Gao et al.
NATURE COMMUNICATIONS (2022)
Attenuation of NLRP3 Inflammasome Activation by Indirubin-Derived PROTAC Targeting HDAC6
Zhuoxian Cao et al.
ACS CHEMICAL BIOLOGY (2021)
Indomethacin-based PROTACs as pan-coronavirus antiviral agents
Jenny Desantis et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Development of a PROTAC-Based Targeting Strategy Provides a Mechanistically Unique Mode of Anti-Cytomegalovirus Activity
Friedrich Hahn et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Targeted protein degraders crowd into the clinic
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2021)
PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
Si-Min Qi et al.
FRONTIERS IN PHARMACOLOGY (2021)
Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation**
Xiaoxuan Su et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Hydrophobic Tagging-Mediated Degradation of Transcription Coactivator SRC-1
So Ra Choi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Targeted Protein Degradation: The New Frontier of Antimicrobial Discovery?
Matthew Powell et al.
ACS INFECTIOUS DISEASES (2021)
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
Shanique B. Alabi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Targeted protein degradation in antibacterial drug discovery?
Pooja Gopal et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2020)
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Xin Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
PROTAC Technology: Opportunities and Challenges
Hongying Gao et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
Sajid Khan et al.
ONCOGENE (2020)
Targeting the SARS-CoV-2 RNA Genome with Small Molecule Binders and Ribonuclease Targeting Chimera (RIBOTAC) Degraders
Hafeez S. Haniff et al.
ACS CENTRAL SCIENCE (2020)
Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2
Alina Mares et al.
COMMUNICATIONS BIOLOGY (2020)
PROTAC Molecules for the Treatment of Autoimmune Disorders
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2019)
ClpP Protease, a Promising Antimicrobial Target
Carlos Moreno-Cinos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Structure of McsB, a protein kinase for regulated arginine phosphorylation
Marcin J. Suskiewicz et al.
NATURE CHEMICAL BIOLOGY (2019)
Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models
M. Catarina Silva et al.
ELIFE (2019)
Structural Basis for Recruitment of DAPK1 to the KLHL20 E3 Ligase
Zhuoyao Chen et al.
STRUCTURE (2019)
Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations
Melissanne de Wispelaere et al.
NATURE COMMUNICATIONS (2019)
The antibiotic cyclomarin blocks arginine-phosphate-induced millisecond dynamics in the N-terminal domain of ClpC1 from Mycobacterium tuberculosis
Katharina Weinhaupl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Specific MHC-I Peptides Are Induced Using PROTACs
Stephanie M. Jensen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Arginine phosphorylation marks proteins for degradation by a Clp protease
Debora Broch Trentini et al.
NATURE (2016)
Design of a PROTAC that antagonizes and destroys the cancer-forming X-protein of the hepatitis B virus
Kristopher Montrose et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Inhibitor Mediated Protein Degradation
Marcus J. C. Long et al.
CHEMISTRY & BIOLOGY (2012)
The Natural Product Cyclomarin Kills Mycobacterium Tuberculosis by Targeting the ClpC1 Subunit of the Caseinolytic Protease
Esther K. Schmitt et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics
Ashley R. Schneekloth et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)